Multi-Asset

Multi-Asset Strategy Quarterly – January 2021

In this edition, Philip Saunders discusses the outlook for in 2021, Sahil Mahtani explores the five core themes we expect to be the key long-term structural drivers over the next decade, in addition to how COVID has impacted them, and Russell Silberston reviews recent policy announcements by the major central banks.

Jan 20, 2021

25 minutes

In this edition, Philip Saunders discusses the outlook for in 2021, Sahil Mahtani explores the five core themes we expect to be the key long-term structural drivers over the next decade, in addition to how COVID has impacted them, and Russell Silberston reviews recent policy announcements by the major central banks.

Multi-Asset Strategy Quarterly - January 2021

01
Market Review - Q4 2020
02
2021 outlook - from recovery to reflation
03
Road to 2030
04
Policy review
05
Summary of high conviction asset class views
06
Equity views
07
Fixed Income views
08
Currency views
09
Commodity views
01

Market Review - Q4 2020

Close-up view of beautiful curved glass building
The mood was heavily in favour of risk assets over the quarter, with news of successful vaccine trials prompting a sharp rotation into cyclically exposed assets.

Global risk assets moved materially higher in the final quarter of 2020 following positive developments regarding key issues such as COVID-19 vaccines, fiscal stimulus in the US and a Brexit deal. Vaccines with better-than-expected efficacy rates were developed, authorised and deployed in the UK, Europe and US. In light of continued economic challenges, central bankers confirmed they would keep financing conditions favourable, whilst in the US an agreement was made with respect to additional fiscal stimulus. Elsewhere, a Brexit separation deal was finally agreed towards the end of the year. In the US, Joe Biden was elected as the next US President and the market rallied, particularly in those areas most directly linked to his fiscal stimulus and renewable infrastructure. Economic data through the quarter broadly indicated that the recovery still had momentum, although US jobs data showed some cause for concern. More concerning for investors was the increase in COVID-19 case numbers and subsequent reintroduction and/or tightening of restrictions across a number of countries.

Following the vaccine news, global equities posted double-digit-plus returns during the quarter with cyclically exposed assets leading the charge. Emerging market equities in aggregate outperformed developed market equities, led by Asia-ex Japan. The S&P 500 index ended the year at another record level, posting double-digit returns, while Europe and the UK reached post pandemic highs. There were similar outsized risk-on moves in the high yield corporate bond market, as Europe outperformed the US. In emerging markets, both sovereign bonds and currencies posted positive, and in some cases high, returns.

As a “risk-on” rotation prevailed, performance of developed market government bonds was mixed. In reaction to a slew of positive news, US Treasuries sold off and the yield curve steepened, whilst other developed market sovereign bonds, such as those in the UK and Germany, generated a small positive return. Investment grade corporate bonds in both the US and Europe generated positive returns, attributed to a supportive technical backdrop as the asset class continued to see inflows from both central banks and investors. The US dollar weakened to fresh lows since April 2018 amidst the cautiously optimistic tone seen in the markets and the commitment to highly accommodative policy from the US Federal Reserve, with this benefiting other currencies such as the euro and the Japanese yen, whilst sterling also made gains following the post-Brexit trade deal agreement.

Gold had a challenging start to the quarter but recovered in December to generate a small positive return of c. 1%, ending the quarter just below $1,900/oz.  

Authored by

Multi-Asset team

Important Information

This information may discuss general market activity or industry trends and is not intended to be relied upon as a forecast, research or investment advice. The economic and market views presented herein reflect Ninety One judgment as at the date shown and are subject to change without notice. There is no guarantee that views and opinions expressed will be correct, and Ninety One’s intentions to buy or sell particular securities in the future may change. The investment views, analysis and market opinions expressed may not reflect those of Ninety One as a whole, and different views may be expressed based on different investment objectives. Ninety One has prepared this communication based on internally developed data, public and third party sources. Although we believe the information obtained from public and third party sources to be reliable, we have not independently verified it, and we cannot guarantee its accuracy or completeness. Ninety One’s internal data may not be audited.

Investment involves risks. Past performance is not indicative of future performance. Any decision to invest in strategies described herein should be made after reviewing the offering document and conducting such investigation as an investor deems necessary and consulting its own legal, accounting and tax advisors in order to make an independent determination of suitability and consequences of such an investment. This material does not purport to be a complete summary of all the risks associated with this Strategy. Ninety One does not provide legal or tax advice. Prospective investors should consult their tax advisors before making tax-related investment decisions.

In Singapore, this communication is issued by Ninety One Singapore Pte. Limited (company registration number: 201220398M).

Except as otherwise authorised, this information may not be shown, copied, transmitted, or otherwise given to any third party without Ninety One’s prior written consent. © 2021 Ninety One. All rights reserved. Issued by Ninety One.

Past performance shown are not indicative of future performance. Investors are reminded that investment involves risk. Investors should read the prospectus and product highlights sheets of the funds which are available from ninetyone.com/en/singapore or any of the appointed distributors before making any investment decision. Please contact your financial advisor if you are in doubt of any information contained in this website. The value of the shares in the fund and the income accruing to the units, if any, may fall or rise.

By clicking on the hyperlink of Investor relations below, you are leaving this website with information specific for retail investors in Singapore and entering the global website.

Please note that the global website is not intended to target investors in Singapore. It has not been reviewed by the Monetary Authority of Singapore (“MAS”). The website may contain information on funds and other investments products that are not authorised or recognised by the MAS and therefore are not available to retail investors in Singapore. The prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares of these funds and/or other investment products may not be circulated or distributed, nor may such shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore. The website may also contain information on investment services / strategies that are purported to be carried out by an Ninety One group company outside of Singapore.

Any product documents and information contained in this website are for reference only and for those persons or entities in any jurisdictions or country where the information and use thereof is not contrary to local law or regulation.

This website has not been reviewed by the Monetary Authority of Singapore. Issued by Ninety One Singapore Pte Limited (Co. Reg. No. 201220398M).